A biotechnology company developing next-generation T cell receptor (TCR) T cell engager (TCE) therapeutics for cancer and autoimmune diseases
t-therapeutics.comLinkedInCambridge, UKBiotechFounded 2022
5 sources · checked 1 time, last 1h ago
The company release is preferred for the round details. Sources agree on the $133 million Series B; European Biotechnology additionally states the combined Series A and B total of $224 million.; not on the page it cites, so not applied: stage, amount, date
2 sources
The announcement dateline is Cambridge, England, but the source does not state the company’s headquarters.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series B | $133M $224M to date | 2026-11-05 | Advent Life Sciences, British Business Bank | 5 outlets. #37 in Trending |
5 sources · checked 1 time, last 1h ago [ VERIFIED · CORRECTED ] read against 4 of 5 sources The company release is preferred for the round details. Sources agree on the $133 million Series B; European Biotechnology additionally states the combined Series A and B total of $224 million.; not on the page it cites, so not applied: stage, amount, date | ||||
T-Therapeutics develops next-generation T cell engagers for cancer and autoimmune diseases, targeting previously undruggable targets to improve patients' lives.
Checked against 10 sources today
| Series A [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $59.8M £48 million ($59 million) | 2023-11-15 | Cambridge Innovation Capital, Digitalis Ventures, F-Prime Capital, Sofinnova Partners | No recent discussion |
2 sources [ VERIFIED · CORRECTED ] read against 1 of 2 sources
The announcement dateline is Cambridge, England, but the source does not state the company’s headquarters. [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]2 pages read: t-therapeutics.com, sofinnovapartners.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]correctedchecked against 1 of 2 sources·[ BRANDING ]logo and colour from the homepage·[ AGENT ]company research by the Firecrawl agent | ||||